2 unknown. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Unknown 2 |
Follow Sun Yan: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Toripalimab Plus TPF Chemotherapy and Radiotherapy for LA-HPSCC Toripalimab - Hypopharyngeal Neoplasm Malignant Primary | Phase 2 | Unknown | Sun Yan | 81 | 2020-10-30 | 2020-11-10 |
| Second-Line Chemotherapy Combined With Endostatin for Recurrent/Metastatic HN Epithelial Tumors second-line chemotherapy, Recombinant human endostatin - Head and Neck Neoplasms | Phase 2 | Unknown | Sun Yan | 53 | 2019-07-29 | 2020-10-23 |
Head and Neck Neoplasms (1) · Hypopharyngeal Neoplasms (1)
Drug Therapy (1) · Endostatins (1) · endostar protein (1) · toripalimab (1)
China (2)
Yan Sun, MD (1)